EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
At EAHP, we are committed to transparency in our governance, ethical standards, and funding practices. This section provides open access to our foundational documents, including the EAHP Statutes, Code of Conduct, and Funding Sources. By sharing these resources, we aim to uphold accountability and foster trust with our members, partners, and the public.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
CPS is a Member of EAHP since 1998.
Address: Masarykova 2, 10000 Zagreb, Croatia
Tel: +385 1 48 72 849
Fax: +385 1 48 72 853
Email: hfd-fg-ap@zg.t-com.hr
Website: www.farmaceut.org
The CPS has 1,800 members and represents 77 hospital pharmacists working in the 45 hospital pharmacies within Croatia. The total number of pharmacists in Croatia is 3,500.
Since 2008 there is a legally defined hospital pharmacy specialisation which lasts 3 years (1 year theoretical and 2 years practical/clinical experience). It is not mandatory to complete this training to work as a hospital pharmacist in Croatia.
Upon completion of the program the student acquires theoretical and practical knowledge which promotes and provides proper and safe use of medicines, with a view to:
Additionally it is possible to undertake a 2 year postgraduate course in clinical pharmacy.
Publications:
Darija Kuruc Poje, univ.mag.pharm., clinical pharmacist (General Hospital “Dr. T. Bardek “Koprivnica)
Mr.sc. Vesna Mađarić, MD, infectologist (General Hospital “Dr. T. Bardek “Koprivnica)
Vlatka Janeš Poje, MD, microbiologist (Department of Public Health Koprivnica County)
Description:
From the 1st September 2017 at the General Hospital “Dr. Tomislav Bardek”, the project of the Antibiotic Stewardship team (A-team) implementation was initiated by infectologists, microbiologists and clinical pharmacist. The aim was rationalizing the treatment of patients with the most severe infections. The A-team goal is to optimize clinical outcomes by minimizing adverse effects of antibiotics, increasing susceptibility to targeted antibiotics and reducing costs. In recent years, there has been an increase in the consumption of antibiotics used as the last line of treatment when other antibiotics no longer work (the so-called antibiotic reserve, AR), which is why we started with the pilot project at our institution. The pilot proved to be extremely successful, which was the reason of presenting the results of the project to the Ministry of Health and all the heads of county and general hospitals on 25th of April 2018. Our hospital, also organized a professional meeting on 15th of June 2018 for all clinics, county, general and special hospitals, i.e. directors and their future A-teams, where, with distinguished guest lecturers (from the University Hospital Centre Zagreb, the University Hospital for Infectious Disease Dr. Fran Mihaljević, Zagreb and the Faculty of Pharmacy and Biochemistry, University of Zagreb), we shared our experiences and ways of implementation in hospitals.
BACKGROUND:
Antimicrobial resistance poses an increasing problem by endangering the health and safety of patients in all health environments. It is estimated that by 2050 mortality from antimicrobial resistance will amount to 10 million, which will exceed 8.2 million cancer deaths and 1.5 million diabetes deaths. Almost half of the prescribed antibiotics in hospitals are unnecessary or inappropriate, as research showed. Appropriate antimicrobial therapy dose no longer include, a simple selection of empirical or therapeutic antibiotics that will suitably act on the causative agent in a suitable patient, but involves a set of complex procedures for which the entire Antibiotic Stewardship team (A-team) is required. A particular problem is the antibiotics used in the last line of treatment when other antibiotics no longer function (the so-called antibiotic reserve, AR) whose quantity has increased significantly in recent years. Despite evidence of the benefits of A-team team implementation, it has still not been recognized and applied in Croatia. As a consequence, the A-team implementation project was started in the General Hospital “Dr. Tomislav Bardek “Koprivnica on 1st September 2017.
OBJECTIVE:
To show through the multidisciplinary collaboration of infectologists – physician, microbiologist -physician and clinical pharmacist, as compulsory A-team members, who implement and coordinate interventions aimed at the proper application of antimicrobial therapy and the ability to improve treatment outcomes.
METHODS:
Using a prospective audit and feedback strategy which means an empirically applied antibiotic evaluation and audit with intervention and feedback to a clinician, the clinical pharmacist validates and issues AR based on the interpretation of the findings of the microbiologist and the clinical findings of the infectologist.
RESULTS:
In the period of 7 months (from 01.09.2017 to 31.03.2018) of the A-team implementation compared to the same period (from 01.09.2016 to 31.03.2017) without A-team, the consumption of defined daily doses of AR to 100 bed-days was reduced and thus financial spending. The aforementioned correlates with reduced number of patients treated with AR for 57%, ie from 938 to 402 (Fisher exact test, OR = 2,40, 95%CI = <2,13; 2,72>, p < 2.2*10^-16 => p < 0,001) without significant impact on mortality (the general mortality rate before A-team was 43.66 and after 40.30).
CONCLUSION:
Multidisciplinary approach of A-team enabled optimization of clinical outcomes while minimizing unwanted consequences of using AR.
LITERATURE:
